As a Medical Writer at Calyx, Sally Han develops Independent Review Charters (IRCs), clinical data forms, results reports, and other protocol-specific documents in support of independent review. Leveraging her training in pharmacy and English‑Chinese interpreting, she has provided support on Chinese and global clinical trials. Prior to joining Calyx, Sally was a Medical Copywriter at a private hospital in Shanghai, where she created and translated physician-related policies, SOPs, medical record templates and other documents.
As a Senior Medical Writer with Calyx since 2020, Paivi is responsible for creating independent review charters and other clinical documents intended for submission to regulatory authorities on behalf of Calyx’s clients. She leverages her extensive experience to provide subject matter expertise to sponsor teams conducting imaging clinical trials across various therapeutic areas such as neurology, oncology, ophthalmology, and cardiology. Paivi has authored more than 15 peer reviewed publications in such prestigious journals as the Journal of Neuroscience, the Journal of Neurophysiology, and Frontiers in Molecular Neuroscience.
Since joining Calyx in 2009, Katarina has had multiple, escalating roles in the department of medical writing. She leverages her extensive medical writing experience to create comprehensive and reliable Independent Review Charters, including those intended for regulatory submission. Her expertise spans multiple indications across a wide array of therapeutic areas, including oncology, CNS, and musculoskeletal disease states, with a strong emphasis in haemato-oncology. A dedicated medical writing professional, Katarina is frequently featured at industry conferences and has published numerous times in peer-reviewed journals.
Kim has held roles of increasing responsibility in Medical Writing since joining Calyx in 2019. Currently the director of a global medical writing team, she standardizes processes to enhance the productivity, quality and timeliness of Calyx’s medical writing services while actively contributing to documentation requirements describing central review assessments in clinical trials involving imaging-based endpoints. Throughout her career, Kim has been motivated by opportunities to create and add value to the teams she has worked on, drawing on her experience and lessons learned from regulatory feedback to improve the quality and rigor of medical writing deliverables.